RK
Ritesh Kantilal Jain
About Ritesh Kantilal Jain
Data last updated:
Ritesh Kantilal Jain was a Director at Rrakov Exim Private Limited (2015–2024), Director at Pharex International Private Limited (2015–2016) and Designated Partner at Rrakov Pharmaceuticals Llp (from 2017). The companies operate in Chemicals and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rrakov Exim Private Limited U46497MH2015PTC270279 | Director | 19 Nov 2015 | 2015 | Active | |
| Pharex International Private Limited U74120MH2014PTC258517 | Director | 14 Sep 2015 | 2014 | Strike Off | |
| Rrakov Pharmaceuticals Llp AAK-4992 | Designated Partner | 05 Sep 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ritesh Kantilal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ritesh Kantilal Jain
Ritesh Kantilal Jain was first appointed on 14 Sep 2015 as Director at Pharex International Private Limited. The most recent appointment on record is 05 Sep 2017 at Rrakov Pharmaceuticals Llp.
Ritesh Kantilal Jain held 3 earlier board appointments: Rrakov Exim Private Limited (Director, 19 Nov 2015 to 06 Apr 2024); Pharex International Private Limited (Director, 14 Sep 2015 to 31 May 2016); Rrakov Pharmaceuticals Llp (Designated Partner, from 05 Sep 2017).